Economic Consequences of the Overuse of Short-Acting ß-Adrenergic Agonists in the Treatment of Asthma in Spain

Antonio Valero, Vicente Plaza(Hospital de Sant Pau), Stacey L. Simon(Children's Hospital Colorado), Margarita Capel(AstraZeneca (Spain)), Aram Sicras-Navarro(Health Economics and Outcomes Research (United Kingdom)), Javier Nuevo(AstraZeneca (Spain)), Antoni Sicras‐Mainar(Health Economics and Outcomes Research (United Kingdom))
Journal of Investigational Allergology and Clinical Immunology
November 26, 2021
Cited by 7


Related Papers